Merck and Eisai said on Friday a combination of their cancer therapies failed to extend the lives of patients with a type of ...

A team of researchers from NUS has developed a novel method to enhance the precision of cancer treatment using gold ...

Co., Inc. (NYSE:MRK) and Eisai Co., Ltd. (TYO:4523) have announced the latest outcomes from their Phase 3 LEAP-015 trial, ...